RVMD earnings: real EPS beat/miss history, analyst consensus Buy, P/E -25.74. Updated 2026-07-23.
Revolution Medicines (RVMD) Research Hub
Revolution Medicines (RVMD) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 203.77 USD (-1.88%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -25.74, market cap 38.93B. This hub links to the full technical, earnings and options research available for RVMD.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 203.77 USD (-1.88%) |
| 52-week range | 152.89 USD – 221.5 USD |
| Trend regime | Range |
| 14-day RSI | 48.5 (Neutral) |
| Trailing P/E | -25.74 |
| Market cap | 38.93B |
| Dividend yield | 0.00% |
Available research for RVMD
Covered Call on RVMD: how it works, illustrative setup around the real 203.77 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on RVMD: how it works, illustrative setup around the real 203.77 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on RVMD: how it works, illustrative setup around the real 203.77 USD price, max profit/loss, breakeven and when to use it. Educational.
RVMD technical analysis: range, last 203.77 USD, RSI 48.5, 52w range 152.89 USD–221.5 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is RVMD in?
Revolution Medicines (RVMD) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is RVMD in an uptrend or downtrend?
As of 2026-09-11, RVMD is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is RVMD's trailing P/E ratio?
RVMD's trailing P/E is -25.74, with a market cap of 38.93B. See the earnings research page for full valuation detail.